Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Heme/Onc Exam 3 > Leukemia and other Myeloproliferative disorders > Flashcards

Leukemia and other Myeloproliferative disorders Flashcards

1
Q

These make up the cellular components of
our immune system

A

Leukocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Innate vs. Adaptive immunity

A

○ Innate: Present and circulating, always on
the offensive against pathogens
○ Adaptive: Adapt to presence of pathogen by
activating and creating
mechanisms for tagging

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Neutropenia

A

● Abnormally low number of Neutrophils.
● Neutropenic patients are at significantly
increased risk of infection, especially
from bacteria and fungi.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Some Possible causes of neutropenia:

A

● Aplastic anemia
● Overwhelming septicemia
● Marrow obliteration by malignancy or cancer treatment
● Drugs (more than 70, including PCN,
phenytoin, etc)
● Dialysis
● Folate/Vitamin B12 Deficiency
● Familial neutropenia
● Idiopathic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Neutrophilia

A

● Increased number of Neutrophils.
● Some causes of neutrophilia are not
pathologic, but just in response to normal physiologic processes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Some Possible causes of neutrophilia

A

● Steroid therapy
● Bacterial infection
● Early Viral infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Lymphocytosis

A

● Increase in the number of Lymphocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Some Possible causes of lymphocytosis

A

● Viral infections
● Thyrotoxicosis
● Lymphoid leukemia
● Chronic infection
● Drug reactions
● Allergic reactions
● Autoimmune diseases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Lymphocytopenia

A

● Decreased number of Lymphocytes.
● Lymphocytopenia is considered a normal
variant in about 22% of the healthy
population

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Some Possible causes of Lymphocytopenia

A

● Normal variant
● Idiopathic
● Human Immunodeficiency Virus infection
● AIDS
● Bone marrow suppression after Chemotherapy
● Some drugs
● Burns
● Trauma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Monocytosis

A

● Increased number of Monocytes.
● Mature Monocytes are phagocytic and a
key player in the innate immune
response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Half of our total
number of Monocytes
are stored in the
____

A

spleen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Some Possible causes of Monocytosis

A

● Inflammation
● Infection
● Malignancy
● Tuberculosis
● Myeloproliferative Disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Eosinophilia

A

● Increased number of Eosinophils.
● One of the granulocytes.
● Present in relatively small number
throughout the body.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Some Possible causes of Eosinophilia

A

● Allergic reactions
● Asthma
● Drug reactions
● Parasitic infections (sometimes)
● Fungal infections (sometimes)
● Addison’s Disease
● Malignancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Basophilia

A

● Increased number of Basophils.
● Also one of the granulocytes.
● The least prominent of the white blood
cell type

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Circulates in the blood and will release
histamine when stimulated by inflammation or
infection

A

Basophils

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Some Possible causes of basophilia

A

● Hypersensitivity reactions
● Drug reactions
● Inflammatory reactions
● Chronic myeloid leukemia
● Hodgkin’s Disease sometimes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Malignancy of blood cell origin = ____ Malignancies

A

Hematologic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Malignancies of the Myeloid Progenitor line (erythrocyte, granulocyte,
platelet) are typically called _____

A

Myeloid, Myelogenous, or Myeloproliferative

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Malignancies of the Lymphoid Progenitor line are typically called
_____

A

Lymphoid or Lymphoblastic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

f the malignancy arose in the bone marrow and may involve the peripheral blood, we refer to it as a ____

A

Leukemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Most Acute Leukemias arise with no ____

A

clear cause

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

There are two main types of Acute Leukemia:

A

○ ALL: Acute Lymphoblastic Leukemia
○ AML: Acute Myelogenous Leukemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Similarities in ALL and AML

A

Symptoms are very similar
○ Physical exam signs are similar
○ Diagnostic findings are similar, but a few
very important differences (know these!)
○ Treatment is similar as well

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

_____: Lymphoid Progenitor Cells in the bone marrow become malignant and begin to replicate wildly

A

ALL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

______: Myeloid Progenitor Cells (precursor to RBCs, granulocytes, monocytes, platelets) become malignant and proliferate wildly

A

AML

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

May be classified as B-cell or T-cell in origin

A

ALL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

____ is the most common childhood malignancy

A

ALL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

___ has a Known connection to Down Syndrome

A

ALL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

ALL epidemiology

A

○ Hematologic malignancy commonly referred to as ALL.
○ The incidence of ALL peaks at the age of 5 years (3-7).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

AML Epidemiology

A

○ Hematologic malignancy commonly known as AML.
○ Accounts for 80% of all new cases of adult acute leukemias.
○ Cause is unknown in most cases, but
has been connected to radiation,
chemo, and Down Syndrome.
○ Can be preceded by Myelodysplastic
Syndrome (MDS) or CML

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Median age of AML

A

■ Primarily occurs in adults over 50 years of age (median = 60)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Signs and Symptoms (both AML and ALL)-

A

○ Most patients have been ill only for days or weeks.
○ Chief complaint may be fever, fatigue, weight loss, irritability, arthralgias, bleeding (often from gums).
○ If CNS involvement, may have headache, stiff neck, visual disturbances, or vomiting
○ Gingival hypertrophy from leukemic infiltration is common

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Physical exam of both AML and ALL may reveal

A

■ Pallor
■ Petechiae
■ Ecchymosis
■ Hepatosplenomegaly (more common
with ALL)
■ Lymphadenopathy (more common
with ALL)
■ Papilledema
■ Retinal hemorrhages
■ Focal neurologic deficits

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

The most dramatic presentation of acute leukemias is that of ____

A

Hyperleukocytosis (“Leukostasis”)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Hyperleukocytosis (“Leukostasis”)

A

Extremely high level of circulating
blasts in the blood leads to clumping of blasts in capillaries
● Impaired circulation
● Headache, confusion
● Dyspnea, respiratory distress
Requires emergent Leukapheresis
and chemotherapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Acute Leukemias diagnosis

A

○ Bone Marrow Biopsy: Marrow will be Hypercellular with > 20% Blasts
○ CBC will generally show a normocytic anemia, thrombocytopenia, and often Neutropenia.
○ WBC count can be low, normal, or high- Sometimes very high (even > 100,000 cells/mm 3 )
○ Hallmark of both:
■ Pancytopenia with Circulating Blasts (immature WBCs)
● Circulating Lymphoid or Myeloid blasts
○ Terminal Deoxynucleotidyl transferase is also diagnostic for ALL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Hallmark of both ALL and AML

A

Pancytopenia with Circulating Blasts (immature WBCs)
● Circulating Lymphoid or Myeloid blasts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Chest X-ray in ALL may reveal
an _____

A

Anterior Mediastinal mass,
suggestive of a T-cell ALL
(Malignant enlargement of the thymus)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Peripheral Blood Smear in AML may show _____

A

Auer Rods
- Pathognomonic and diagnostic for AML

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Treatment for both ALL and AML includes _____

A

“Induction Chemotherapy”, which is essentially aggressive combination chemo with the goal of “inducing” remission
(Taking out the bone marrow until it is essentially wiped out, hoping it will recover without the leukemia re-manifesting)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Acute Leukemia should be Tx’d by _____

A

Hematology Oncologist

44
Q

Acute Leukemia is considered a ____, especially
among younger patients without significant comorbidities

A

curable disease
*in patients up tp 60 YOA

45
Q

For AML, treatment produces complete remission in ____% of those under 60 YOA, and ____% in older patients

A

80-90; 50-60

46
Q

For ALL, treatment produces complete remission in _____% of pediatric cases, and in about ___% of adult cases

A

95-98; 90

47
Q

Chemotherapy for CNS infiltration

A

Intrathecal chemotherapy (cranial
or lumbar) is becoming common practice,
even for prophylaxis in some

48
Q

_____ is sometimes needed and may
be the best chance for a cure in many patients

A

Allogeneic stem cell replacement

49
Q

T/F Once acute leukemia has recurred after initial chemotherapy, the
prognosis is poor

A

T

50
Q

Chronic Myelogenous Leukemia

A

● CML is a disease of the middle aged (45-60, mean of 50-55 yrs).
● Accounts for approximately 15% of adult leukemia

51
Q

There has been increased incidence of CML among persons with history of ____

A

exposure to high level ionizing radiation

52
Q

Chronic Myelogenous Leukemia is Characterized by the ____

A

Philadelphia Chromosome
○ Translocation between long arms of chromosomes 9 and 22
○ Moves the protooncogene abl next to breakpoint cluster (bcr)
○ bcr/abl fusion gene encodes for pathologic novel protein

53
Q

Chronic Myelogenous Leukemia Pathophysiology

A

○ Proliferation of myeloid cells that retain their
capacity to differentiate initially.

54
Q

Phases of CML

A

○ Initially, the Chronic Phase:
■ WBCs > 100,000, with < 5% blasts
■ Does not behave like malignancy
■ If left untreated, is inherently unstable
and will progress to Accelerated Phase
○ Accelerated Phase:
■ > 5% blasts, but still < 30%
■ 4-6 months before entering Blast Phase
○ Blast Crisis Phase (acute phase):
■ The aggressive, acute stage of the
disease process
■ Blood or Marrow shows > 30% blasts

55
Q

This is a form of Secondary Acute
Leukemia and is often
indistinguishable from AML clinically

A

CML in a blast crisis phase

56
Q

Most patients diagnosed in the Blast
Phase of CML have poor response to therapy
and _____

A

die within 1-2 years

57
Q

Chronic Myelogenous Leukemia S/S

A

○ May be asymptomatic, especially if in Chronic or Accelerated phases.
○ May have LUQ pain secondary to enlarged spleen.
○ May have fever, weight loss, arthralgias, bleeding
○ Physical exam usually reveals obvious splenomegaly, ecchymosis, and/or bone tenderness.
○ Rarely patients will present with blurred vision, neuro deficits, or pulmonary distress secondary to leukostasis

58
Q

Diagnosis of CML

A

CBC for suspected CML will show WBC increased, often > 100,000.
■ Increased granulocytes (especially Neutrophils)
○ May see normocytic anemia

59
Q

Bone Marrow Biopsy for CML would be ____-

A

hypercellular with a left shift, even if <5% blasts

60
Q

Hallmark of CML

A

PCR detects bcr/abl gene from the Philadelphia Chromosome

61
Q

Most people (90%) are diagnosed with CML while in _____

A

Chronic Phase

62
Q

Treatment and Referral for CML

A

○ Should be managed early by Hematology Oncologist.
○ Treatment during Chronic Phase is important to delay conversion to Blast Phase.
○ Treatment is chemotherapy class called Tyrosine Kinase Inhibitors (Imatinib [Gleevec] is most common, although there are others) with or without Allogeneic Stem Cell Transplant

63
Q

Prognosis of CML

A

○ Patients with good molecular response to the tyrosine kinase
inhibitor treatment have excellent prognosis.
■ Essentially 100% survival based on recent studies
○ More than 80% of later recurrences occur 6-8 months after stopping tyrosine kinase inhibitor therapy.
■ 90-95% of recurrences regain remission with re-treatment
○ Average life expectancy for CML diagnosed while in the acute
Blast Phase is poor at approximately 3 months

64
Q

Chronic Lymphocytic Leukemia

A

● CLL usually occurs in adults over the age of 50 years.
○ Median age is 70 years
○ Twice as common in males
● Most common form of adult leukemia in Western world

65
Q

Pathophysiology of CLL

A

○ CLL is a clonal malignancy of B-Lymphocytes.
○ The disease process is indolent with slowly progressive accumulation of lymphocytes.
○ Eventually, immunosuppression and bone marrow failure develop,
with possible lymphocytic organ infiltration

66
Q

Chronic Lymphocytic Leukemia S/S

A

○ Many patients are asymptomatic and this is diagnosed incidentally on routine CBC (asymptomatic lymphocytosis).
○ If symptomatic, may have weakness, fatigue, and/or infections.
○ Physical examination may reveal lymphadenopathy (80%) and/or
hepatosplenomegaly (50%).

67
Q

CLL is a clonal malignancy of _____

A

B-Lymphocytes

68
Q

CBC findings for CLL

A

CBC classically shows WBC count of > 15,000/mm 3 .
■ Many may be as high as 100,000/mm 3 .
○ CBC Differential reveals the predominant WBC to be small Mature Lymphocytes.
○ Normocytic anemia is common.

69
Q

PBS findings for CLL

A

Peripheral blood smear shows mature
lymphocytes with some characteristic Smudge
Cells (disintegrating Lymphocytes).

70
Q

Bone marrow biopsy findings of CLL

A

> 30% well-differentiated Lymphocytes.

71
Q

CBC giveaway for CLL

A

CBC Differential reveals the predominant WBC
to be small Mature Lymphocytes.

The lymphocytes are high as opposed to other cells

72
Q

Treatment and Referral for CLL

A

○ Because CLL is so indolent, we do not generally treat those who
are asymptomatic with stable disease.
■ Watchful waiting for Sxs is usually initial treatment plan

73
Q

About 10% of CLL patients may develop associated _____

A

Autoimmune Hemolytic Anemia (Positive Coombs Test)
Steroids would be the treatment in this case

74
Q

Treatment and Prognosis of CLL

A

○ Targeted chemotherapy agents have improved the prognosis in recent years.
■ Patients who are asymptomatic or early stage at diagnosis generally have a life expectancy of 10-15 years and can be reassured they can live a normal life.
○ Patients diagnosed in later stages (generally symptomatic) have a 5-year survival of more than 50%
○ Allogeneic Stem Cell Transplant are reserved for those with high-risk and resistant forms of CLL

75
Q

Hairy Cell Leukemia

A

● Rare form of Leukemia that usually presents in late middle aged
(median age of 55 years).
○ 5 times more common in males

76
Q

Hairy Cell Leukemia pathophysiology

A

○ Malignancy of hematopoietic stem
cells differentiated as mature
B-Lymphocytes with hairy cytoplasmic
projections.
○ Usually see Pancytopenia with anemia,
thrombocytopenia, and neutropenia

77
Q

Hairy Cell Leukemia S/S

A

○ Most patients present with gradual
onset of fatigue.
○ Some present with concerns of
massively enlarged spleen
○ The disease is indolent and usually
plagued with recurrent infections,
including Mycobacterial

78
Q

Some present with concerns of
massively enlarged spleen in what?

A

Hairy cell leukemia

79
Q

Hairy Cell Leukemia diagnosis

A

Pancytopenia is the hallmark.
■ Anemia, Thrombocytopenia, Neutropenia
○ Peripheral Blood Smear may reveal “Hairy Cells”
○ Bone Marrow biopsy confirms characteristic
appearance of the B-Lymphocytes in the marrow

80
Q

Treatment for hairy cell leukemia

A

○ A short course of chemotherapy is often very beneficial and more than 80% experience significant remission
○ More than 95% live longer than 10 years after diagnosis

81
Q

Myeloproliferative Disorders include the following

A

○ Polycythemia Vera
○ Essential Thrombocytosis
○ Chronic Myelogenous Leukemia
○ Acute Myelogenous Leukemia
○ Myelodysplastic Syndromes

82
Q

Myeloproliferative Disorders

A

Multiple disorders due to acquired
clonal abnormalities of the Myeloid
progenitor cell line.

83
Q

all ______ may progress to life-threatening
Acute Myelogenous Leukemia.

A

Myeloproliferative Disorders

84
Q

Polycythemia Vera is also known as

A

Primary Erythrocytosis: this is an acquired
myeloproliferative disease resulting in overproduction of RBCs.

85
Q

______is due to chronic hypoxia states like smoking, COPD, cyanotic heart disease, etc

A

Secondary Erythrocytosis (AKA “polycythemia”)

86
Q

Polycythemia Vera characteristic mutation

A

A mutation in the JAK2 signalling molecule is demonstrated in 95% of cases

87
Q

In polycythemia vera, RBC production happens independently of _____ and
____ is actually low in most cases

A

Erythropoietin; Epo

88
Q

Polycythemia Vera S/S

A

○ Patients complain of episodes of headache, blurred vision, and pruritus (especially after a hot shower/bath).
○ Frequent epistaxis is common, likely
due to engorgement of the mucosal
blood vessels.
○ May have engorged retinal veins.
○ The spleen is usually palpable and is
essentially always enlarged on imaging
○ PV patients have an increased tendency
to experience thrombotic events.
○ May see Erythromelalgia- burning and
throbbing sensation of the hands/feet

89
Q

Polycythemia Vera Diagnosis

A

○ Hematocrit is elevated, >49%.
○ WBC is usually elevated, most often between 10 and 20,000.
○ Platelet count is sometimes elevated, occasionally as high as 1,000,000
○ Erythropoietin level is responsively suppressed.
○ Diagnosis should be confirmed by checking the JAK2 mutation
○ Bone Marrow Biopsy is not necessary, but would reveal panhyperplasia.
○ Iron stores are often depleted - burning up iron to make more RBCs

90
Q

Polycythemia Vera Treatment

A

Treatment of choice is regular Therapeutic Phlebotomy.
○ Occasionally myelosuppressive chemotherapy is indicated
○ Low-dose Aspirin (81 mg) is also recommended, as this reduces
the risk of thrombosis
○ Antihistamines can help with pruritus.

91
Q

When is myelosuppressive chemotherapy indicated in polycythemia?

A

■ For those not responding to or tolerating phlebotomy.
■ Hydroxyurea is widely used, historical preference.
■ Two newer drugs are showing possibly superior results:
● The JAK2 inhibitor Ruxolitinib
● The novel interferon Ropeginterferon Alpha-2b
● These are best for patients with refractory hematocrit without splenomegaly, and are now recommended in front of Hydroxyurea.

92
Q

Most common cause of death in polycythemia vera?

A

Arterial thrombosis

93
Q

Essential Thrombocytosis

A

● An uncommon myeloproliferative disorder.
● The underlying cause is unknown.
● Significant proliferation of megakaryocytes in the bone marrow
occurs and leads to an elevated platelet count.

94
Q

Similarity between Essential Thrombocytosis and polycythemia vera

A

As in Polycythemia Vera, there is a high
frequency of JAK2 mutation (about 50%
of cases)

95
Q

Essential Thrombocytosis incidence

A

● The median age at presentation is 50-60 years.
● ET is slightly more common in females than males

96
Q

S/S of Essential Thrombocytosis

A

○ Often asymptomatic (most commonly)
○ Thrombosis may be presenting sign
■ The risk of thrombosis increases with age
■ May occur at unusual sites, such as hepatic or portal vein
○ Some may experience erythromelalgia (relieved by aspirin)
○ Splenomegaly is present in at least 25% of cases

97
Q

Essential Thrombocytosis hallmark

A

Elevated platelet count
Peripheral blood smear may
reveal abnormally large platelets.

98
Q

Is hematocrit normal or elevated in Essential thrombocytosis?

A

Normal (key differentiator from PV)

99
Q

In the absence of a JAK2 mutation, also check for ____

A

CALR and MPL mutations

100
Q

Treatment of Essential Thrombocytosis

A

■ The treatment of choice is oral Hydroxyurea
■ This can lower the platelet count, with the goal of having
platelets under 500,000

101
Q

In Essential Thrombocytosis patients with lower risk of thrombosis, _____ reduces the risk and also treats erythromelalgia

A

Low-dose Aspirin

102
Q

Myelodysplastic Syndromes

A

● A group of acquired clonal disorders of the hematopoietic stem cells, all considered premalignant (can become AML).
● Idiopathic in most cases, but sometimes linked to prior chemotherapy or radiation treatment.
● Patients are usually over the age of 60 years

103
Q

Myelodysplasia is characterized by the following

A

○ Cytopenias
○ Usually hypercellular bone marrow
○ Morphologic dysplasia
○ Genetic abnormalities

104
Q

Myelodysplastic Syndromes S/S

A

○ Often asymptomatic - Discovered with incidental finding of abnormal CBC
○ Most common symptomatic presentations are generally related to bone marrow failure:
■ Fatigue
■ Recurrent or abnormal infections
■ Bleeding
○ Splenomegaly and pallor are also commonly found.

105
Q

Myelodysplastic Syndromes Diagnosis

A

○ There is no specific, pathognomonic finding.
○ Anemia is generally present
○ The bone marrow is characteristically hypercellular, helping to differentiate this from Aplastic Anemia.
■ Cytogenetic and histologic testing of bone marrow sample helps confirm the dysplasia and diagnosis
○ Separated from AML by less than 20% blasts circulating.

106
Q

Myelodysplastic Syndromes treatment

A

○ Treatments may include blood product transfusions, chemotherapy treatments, and/or stem cell transplants.
○ Prognosis is poor; the course is ultimately fatal, with survival years ranging significantly.
■ The only curative treatment is allogeneic stem cell transplant, which is successful 30-60% of the time
Should always be referred to hematology

Heme/Onc Exam 3 (6 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions